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ABSTRACT 
Attention Deficit Hyperactivity Disorder (ADHD) is a chronic, highly prevalent, 
neurodevelopment disorder in children, which often persists into adulthood. A gap exists among 
healthcare providers’ knowledge of adult ADHD and current screening practices in the primary 
care setting.  The purpose of the project was to improve screening and identification of adult 
ADHD in the primary care setting by enhancing provider knowledge and awareness of the 
disorder. 
A need was identified at a small, rural, facility in Midwestern, North Dakota to improve 
adult ADHD screening practices; thus the adult ADHD Self-Report Scale version 1.1 (ASRS-
v1.1) was implemented among a group of providers for a five month time period. The ASRS-
v1.1 is a six question rating scale which was created by a group of ADHD experts and 
copyrighted by the World Health Organization. The sensitivity of the tool is 68.7 percent while 
the specificity rate is a remarkable 99.5 percent. For the practice improvement project, providers 
were instructed to screen patients displaying signs and/or symptoms of inattention, hyperactivity, 
impulsivity, depression, anxiety, substance abuse, etc. If the screen was found to be a positive, 
recommendations were to refer the patient to a mental healthcare professional.  
The results of the project demonstrated an overall improvement in the screening process 
for adult ADHD.  An increase of patients referred for further diagnostic testing of adult ADHD 
was found.  Providers felt the ASRS v1.1 was a helpful in screening and determining the course 
of care for the patient. Recommendations from the practice improvement project for future 
research include replicating the study with a larger sample size; providing easy access to the 
ASRS v1.1; and screening patients identified as routinely missing appointments for ADHD.  
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CHAPTER ONE. INTRODUCTION 
 Mental health disorders are among the most common causes of disability (Healthy People 
2020, 2013).  Individuals with untreated mental health disorders are at high risk for many 
unhealthy and unsafe behaviors, such as alcohol and illicit drug abuse; violent or self-destructive 
behavior; and suicide.  The most common nationally diagnosed psychiatric disorder in children is 
Attention Deficit Hyperactivity Disorder (ADHD) (Ryan, Katsiyannis, & Hughes, 2011).  It was 
once believed children “out grew” this disorder when adulthood was reached (Boonstra, 2006).  
In recent years, this notion has been re-conceptualized, and ADHD is now considered 
problematic across the lifespan (American Psychiatric Association [APA], 2013; Knutson & 
O’Malley, 2009; McGough & Barkley, 2004).  The disorder is evident in most cultures, 
accounting for approximately 5 percent of the children and 2.5 percent of the adult population 
(APA, 2013).  Adult ADHD is often misunderstood and difficult to diagnose (National 
Association for Continuing Education [NACE], n.d.).  As a result, individuals do not receive 
appropriate treatment and are unable to reach their full potential.  Untreated mental health 
disorders negatively impact one’s physical health, increasing the risk of chronic diseases, such as 
diabetes, heart disease, and cancer (Healthy People 2020, 2013).  Healthy People 2020 (2013) 
has set a national goal to increase the proportion of adults with mental illness who receive 
treatment.  By improving the assessment of individuals with ADHD, healthcare providers can 
assist in decreasing the disease burden of mental health disorders, as well as associated chronic 
comorbid conditions.   
Background 
ADHD is a neurodevelopment disorder with childhood onset before the age of 12 (APA, 
2013; Nigg, Butler, Huang-Pollock, & Henderson, 2002).  The disorder is considered primarily 
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behavioral; however, biological and environmental factors play key roles in development (Fields 
& Hale, 2011; Ryan et al., 2011).  Individuals with ADHD struggle with atypical levels of 
inattention, impulsivity, and hyperactivity in environments such as home, work, school, or other 
various activities (APA, 2013; DuPaul, Weyandt, & Janusis, 2011).  Aggression, non-
compliance, and emotional lability are also prominent in individuals with ADHD (List & 
Barzman, 2011; Sobanski et al., 2010).  Longitudinal studies conducted in the ADHD youth 
demonstrate reduction of hyperactivity and impulsivity with age, but persistence of inattention in 
up to 90 percent of individuals (Wilens, Faraone, & Biederman, 2004).  Throughout a lifetime, 
children diagnosed with ADHD tend to become adults who have a lower occupational status, 
difficulty with relationships, and more misconduct offenses (Muhammad et al., 2011;Von Polier, 
Vloet, & Herpertz-Dahlman, 2012).  Divorce rates are higher, incidence of substance abuse is 
increased, and traffic violations and automobile accidents are more likely (Wilens et al., 2004). 
Women with ADHD demonstrate difficulty with parenting (Knutson & O’Malley, 2009).  Many 
adults with the disorder, diagnosed or undiagnosed, suffer from various forms of depression and 
anxiety (Faraone et al., 2000).  Adults without a childhood diagnosis of ADHD, whom have any 
of the aforementioned characteristics, should be screened.  A family history of the disorder 
should also prompt the provider to screen.  
Significance of Proposed Project 
 There are an increasing number of adults presenting in the clinic setting with complaints 
of symptoms which may be related to undiagnosed ADHD (Matheson et al., 2013; Rostain & 
Ramsay, 2006).  Adults with undiagnosed ADHD can present to primary care with symptoms of 
anxiety and depression, which leads to misdiagnoses and ineffective treatment of the etiology of 
anxiety and depressive symptoms (Matheson et al., 2013).  A study conducted by Matheson et al. 
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(2013) established adults who are not diagnosed with ADHD until adulthood tend to have 
accumulated psychosocial burdens  related to a chronic sense of failure and missed potential in 
numerous aspects of life.  Low self-esteem, a sense of underachievement, and social impairments 
are common in individuals with undiagnosed ADHD and can lead to suicidal ideation. 
Understandably, these individuals are being diagnosed with evident symptoms of anxiety and 
depression; however, the ADHD symptoms are not being treated, further worsening the 
individual’s anxiety and depression.  
 Healthcare providers play a pivotal role in identifying individuals with a potential 
diagnosis of adult ADHD.  Identification and treatment of ADHD can help individuals reach 
their full potential (NACE, n.d.).  Advanced practice nurses (APNs), such as nurse practitioners 
are providers involved in the process.  APNs in primary care screen, diagnose, and manage 
individuals with ADHD (Yearwood, Pearson, & Newland, 2012).  According to the literature 
review conducted for the project, a gap exists among healthcare providers’ knowledge of adult 
ADHD and current screening practices. The purpose of this project was to enhance provider 
knowledge of adult ADHD in a rural clinic by improving screening and the identification of 
adults with the disorder in the primary care setting.  
Healthcare providers should be screening adult individuals with any one of the following 
related complaints: inattention, impulsivity, hyperactivity, depression, anxiety, substance abuse, 
frequently changing jobs, and numerous traffic violations or automobile accidents (Adler & 
Shaw, 2011).  A quick and easy tool, known as the ADHD Self-Report Scale version 1.1 (ASRS 
v1.1), may be beneficial for providers to utilize and assist with the identification of ADHD 
(Harvard Medical School, 2005; Kessler et al., 2007).  Rating tools tend to be valuable and cost-
effective for use by clinicians because significant data can be gathered quickly and indicate the 
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severity of the potential illness or disorder (Buitelaar, Kan, & Asherson, 2011). The ASRS v1.1 
is a symptom checklist of ADHD consisting of eighteen questions, with six of the questions 
being most predictive of the disorder.  The six predictive questions are included in ‘part A’ of the 
instrument.  For the purposes of the project, only the condensed version was utilized (see 
Appendix A).  ‘Part A’ of the ASRS v1.1 has been validated and is considered reliable as 
evidenced by a sensitivity rate of 68.7 percent and specificity rate of 99.5 percent (Adler & 
Shaw, 2011; Harvard Medical School, 2005).  Individuals only need to meet four of the six 
criteria for the screening to be considered positive for ADHD.  The primary care provider can 
then refer to a psychiatric provider for further testing and diagnosis (Pearson & Crowley, 2012).  
Statement of the Problem 
 Adult ADHD is often unrecognized and difficult to diagnose (NACE, n.d.).  Primary care 
providers, including APNs, can be prepared to screen, diagnose, and manage individuals with 
ADHD (Yearwood, Pearson, & Newland, 2012).  The researcher established that a gap exists 
among healthcare providers’ knowledge of adult ADHD and current screening practices in the 
primary care setting based on a thoroughly conducted literature review.  Numerous tools are 
available to assist in the process of screening adults with ADHD.  The ASRS v1.1 was found to 
be reliable and valid with a specificity rate of 99.5 percent, as well as easy to use (Adler, Shaw, 
Sitt, Maya, & Morill, 2009).   
Purpose of the Project 
 The purpose of this project was two-fold.  The first aim was to improve the screening and 
identification of adults with undiagnosed adult ADHD for appropriate referral and treatment 
utilizing the ASRS v1.1. To accomplish an improvement in screening practices, providers’ 
knowledge of adult ADHD needs to be enhanced, which establishes the second goal of the 
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project.   The researcher and committee members designed the project to be minimally stressful 
for willing participants.  Factors included ease of use of the instrument; practicality; and benefits 
to the healthcare professionals and patients.  A definitive end result was to improve the quality of 
life in patients, as in all aspects of healthcare.  
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CHAPTER TWO. LITERATURE REVIEW 
 ADHD is a chronic, highly prevalent, neurobehavioral disorder which may persist into 
adulthood (Buitelaar et al., 2011; Spencer, Biederman, & Mick, 2007).  The disorder came to 
light in the early 1900’s.  The exact cause of the disorder remains unknown; however, numerous 
theories exist.  Etiologies include genetic, environmental, and biologic. Symptoms of ADHD can 
widely vary, but most individuals with the disorder have problems with hyperactivity, 
impulsivity, and/or inattention in at least two settings, severely impacting overall quality of life 
(APA, 2013).  Onset cannot occur in adulthood; though, a delay in diagnosis until adulthood is a 
possibility (Pearson & Crowley, 2012).  Many healthcare providers struggle to identify the 
disorder due to a lack of knowledge, training, and an easy-to-use tool for screening (Adler et al., 
2009).  Symptoms must be present before the age of twelve for adult ADHD to be diagnosed.  
Comorbid conditions, such as mood, conduct, or substance use disorders are almost always 
present.   
History 
 The concept of ADHD originated in 1902 from George Still’s “Defect of Moral Control” 
(Comstock, 2011).  Still’s manuscript related problematic behavior of children to lack of moral 
control (Yearwood et al., 2012).  Medicating with sedatives and hypnotics to reduce deviant 
behavior became apparent in the eighteenth century (Comstock, 2011).  The phrase “minimal 
brain dysfunction” originated in the 1930’s to describe children with hyperkinesis, problems with 
learning, impulsiveness, and a short attention span (Yearwood et al., 2012).  In the 1950’s, the 
disorder was referred to as “hyperactive child syndrome”.  Charles Bradley conducted 
experiments in the mid-twentieth century with the use of stimulants instead of sedatives to 
control behavior (Comstock, 2011).  Stimulant use was discovered to work in children with 
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hyperactivity or inattention and social isolation.  In the 1970’s, Virginia Douglas made 
associations between deficits in attention and impulse control, as well as underdeveloped moral 
intuition.  Also occurring in the 1970’s, was the first recognition of adult ADHD (Buitelaar et al., 
2011).  In the 1990’s, adult ADHD became more frequently diagnosed and treated (Quinn, 
2011).  
The Diagnostic and Statistical Manual of Mental Disorders third edition (DSM-III) began 
recognizing inattention as major component of ADHD (Buitelaar et al., 2011).  The DSM-III 
revised version identified signs and symptoms of the disorder will persist into adulthood in 
approximately one third of children already diagnosed. The DSM-IV identified three subtypes of 
ADHD, which include: predominately inattentive, hyperactive, and combined type (Dobie et al., 
2012).  Six or more of the following criteria under either inattention or hyperactivity and 
impulsivity must be present in order to meet diagnostic criteria.  The DSM-5 continues with the 
same criteria, with the major change being onset before the age of 12 compared to seven in the 
DSM-IV (APA, 2013).  An adult ADHD diagnostic criterion continues to remain unclear as to 
whether or not an individual needs to meet the same “full criteria” as a child (Buitelaar et al., 
2011).   
Incidence and Prevalence 
 In the United States, the incidence of adult ADHD is approximately 2.5 percent (APA, 
2013; Buitelaar et al., 2011).  The predicted prevalence of adult ADHD is about five to six 
percent (Buitelaar et al., 2011).  Only 38 percent of patients diagnosed with ADHD in childhood 
continued to meet “full” criteria as adults.  Significant impairment associated with some 
symptoms of ADHD is present in over 90 percent of adults diagnosed with ADHD as a child.  
According to the Centers for Disease Control and Prevention [CDC] (2013), male children are 
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twice as likely to be diagnosed with ADHD compared to their female counterpart.  Once 
adulthood is reached, the gap decreases between males and females; however, no true male to 
female ratio is established in adults with ADHD (Quinn, 2011). Current research reveals that a 
diagnosis of ADHD is often not made until a person reaches adulthood (Targum & Adler, 2014).  
Pathophysiology 
 As specified beforehand, the origin of ADHD is thought to be primarily related to 
genetics, biologics, and environment (Spencer et al., 2007).   Some of the etiology still remains 
unclear.  Food additives, diet, and lead contamination were all once thought to contribute to the 
disorder, but studies conducted are unable to provide concrete evidence (Kaplan, 2012).    
Genetics  
Based on numerous studies conducted in twins, the mean heritability for ADHD has 
shown to be 76 percent (Faraone & Mick, 2010).  Some genetic studies conducted determined 
regions of the chromosomes 16p13 and 17p11 likely place an individual at higher risk for 
developing ADHD (Spencer et al., 2007).  Genetic variants of the dopamine D4 receptor (DRD4) 
and the dopamine D5 receptor (DRD5) showed evidence of association with ADHD, which 
reached genome-wide levels of significance (Asherson, 2010).  If a child is diagnosed with 
ADHD, there is a 10 to 35 percent chance a first degree relative will also have the disorder 
(Yearwood et al., 2012).  If a parent is diagnosed with ADHD, a 57 percent chance exists that his 
or her child will develop the disorder.  Inattentive symptoms are thought to have pleiotropic gene 
effects, expressed in other clinical disorders, such as dyslexia, hyperactivity-impulsivity 
symptoms with oppositional problems, and ADHD with autism spectrum disorder (Asherson, 
2010).    
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Environment 
Environmental components which are independent risk factors for ADHD include 
maternal smoking and alcohol exposure during pregnancy, secondhand smoke exposure, low 
birth weight, and psychological adversity (Max, Sung, & Shi, 2013; Spencer et al., 2007).  
Psychological adversity factors include exposure to marital discord, low socioeconomic status, 
large family size, paternal criminality, maternal mental disorder, and foster care placement 
(Spencer et al., 2007).  The aforementioned factors play a role in a child’s adaptive functioning 
and emotional health as an underlying predisposition rather than a specific indicator of ADHD.   
Biologic 
The neurobiology of ADHD is not completely understood (Spencer et al., 2007).  Based 
on neuro-imaging studies, children and adults with ADHD have shown to have a decreased size 
of the prefrontal cortex (Daley & Birchwood, 2009; Spencer et al., 2007; Yearwood et al., 2012).  
A decline or impairment in the individual’s prefrontal executive functions is expected.  Such 
functions may include response inhibition and working memory.  Executive function deficits are 
primarily related to symptoms of inattention, and not with hyperactivity or impulsivity. 
Inattention signs and symptoms are closely linked with underachievement in academic 
performance.  Other evidence demonstrates fronto-striatal and cerebellar motor dysfunctions 
present in individuals with ADHD (Pasini, D’Agati, Pitzianti, Casarelli, & Curatolo, 2012).  The 
cerebellum contributes significantly to cognitive functioning (Spencer et al., 2007).  Subcortical 
structures are also found to be smaller with neuroimaging studies.  Such structures include 
caudate, putamen, and globus pallidus, which are part of the neural circuitry underlying motor 
control, executive functions, inhibition of behavior, and the modulation of reward pathways.  
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These frontal-striatal-pallidal-thalmic circuits provide feedback to the cortex for the regulation of 
behavior.   
Neurotransmitter deficits are also thought to contribute to the development of ADHD 
(Pellow, Solomon, & Barnard, 2011; Yearwood et al., 2012).  Low levels of catecholamines and 
serotonin may contribute to lack of focus and concentration.  Imbalances in dopaminergic and 
nonadrenergic systems have been implicated in the core symptoms that characterize the disorder, 
prominently inattention (Spencer et al., 2007).   
Primary Care 
Many healthcare providers believe their knowledge and familiarity with adult ADHD is 
significantly less compared to anxiety and depressive disorders (Adler et al., 2009).  In fact, 
according to one survey, 77 percent of physicians believe adult ADHD is not well understood by 
the medical community.  Seventy-two percent of physicians reported it is significantly more 
difficult to diagnose adult ADHD compared to childhood ADHD.  Reasons contributing to the 
lack of recognition of adult ADHD include notions that it was once thought to be only a 
condition of childhood; the typically lacking of hyperactivity as an obvious symptom in 
adulthood versus childhood; the perception that adult are able to control their impulses or 
improve motivational problems on their own; and lastly, reluctance by providers to treat the 
disorder because of potential abuse of psychostimulant medication (Knutson & O’Malley, 2009.) 
Knowledge of adult ADHD exists, but it is evident more awareness is needed to assist in 
detection of the disorder (Adler & Shaw, 2011).  In order for adults to be diagnosed with ADHD, 
four critical elements must be present: (1) childhood onset, (2) presence of significant symptoms, 
(3) impairment in daily life from these symptoms in at least two settings, and (4) symptoms are 
best explained by ADHD and not another psychiatric disorder (Adler, 2004; Adler & Shaw, 
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2011).  The healthcare providers should be knowledgeable of the critical elements necessary for 
an ADHD diagnosis.  Rating scales, such as the Adult ADHD Rating Scale (ADHD-RS), the 
Adult ADHD Investigator Symptom Rating Scale (AISRS), the Conners rating scale, and the 
ASRS v1.1 are highly valid and reliable instruments to assist with screening and aid in the 
diagnosis of adult ADHD (Adler & Shaw, 2011).   
ADHD Rating Scales 
 Rating scales are valuable because they enable clinicians to obtain a large amount of data 
relatively quickly, including information on presence and severity of symptoms (Adler & Shaw, 
2011).  Most rating scales are commonly in a Likert scale-type format; generally are cost 
effective; and can be helpful with screening, aiding in diagnosis, and measuring response to 
treatment.  In a survey distributed by Adler et al. (2009), “Eight-five percent of physicians 
indicated they would take a more active role in diagnosing and treating adult ADHD if an easy-
to-use, relatively quick to administer screening tool was developed and validated by physicians 
or institutions they respect” (p. 62).  
The ASRS v1.1 has demonstrated good sensitivity and specificity and has a positive 
predictive value between 57 and 93 percent (Adler et al., 2009). As earlier explained, there are 
two versions of this tool; a six question screener and the complete 18-question checklist.  Both 
the condensed and longer versions are available in other languages (Rosler et al., 2006).  In one 
study conducted, the shortened version was found to outperform the full version of the ASRS for 
clinical screening purposes, taking approximately three minutes to administer (Kessler et al., 
2005; Rosler et al., 2006). The differences in sensitivity and specificity of the condensed version 
versus the longer version are slight, but studies demonstrate the six-question screener is a 
stronger tool because of less variation in symptom-level concordance.  The 18-question screener 
12 
 
has a sensitivity of 56.3 percent and specificity of 98.3 percent, while the shortened version has 
an improved sensitivity rate at 68.7 percent and a remarkable specificity of 99.5 percent. Both 
versions of the ASRS v1.1 have been copyrighted by the World Health Organization (WHO) 
(Harvard Medical School, 2005).   
Another tool that can be used to screen adults seeking evaluation of ADHD is the Wender 
Utah Rating Scale (WURS) (McCann, Scheele, Ward, & Roy-Byrne, 2000).  Two different 
formats of the WURS exist, with the short version sensitive in detecting adults with ADHD 72.1 
percent of the time. On the contrary, the scale misclassifies individuals who do not have ADHD 
52.5 percent of the time.  A more recent scale has been created based on the widely used 
psychiatric Symptom Checklist 90 Revised (SCL-90-R) to identify adults with ADHD (Eich et 
al., 2011).  Nine items which are considered to be characteristic of ADHD were taken from the 
SCL-90-R.  The new scale demonstrated a sensitivity of 75 percent and specificity of 54 percent.  
The scale fails to identify 25 percent of true ADHD cases, while a whopping 46 percent of non-
ADHD patients will be falsely identified as having ADHD (Eich et al., 2011).   
 A number of Conners Adult ADHD Rating Scales (CAARS) exist and have general 
acceptance in the psychiatry community (Rosler et al., 2006; Van Voorhees, Hardy, & Kollins, 
2011).  The CAARS scales include a self-report (CAARS-SR), an observer-report (CAARS-
OR), and the CAARS-Investigator (CAARS-INV).  Both the CAARS-SR and CAARS-OR have 
a short and long screening version and are oriented towards the DSM-IV criteria, with measures 
also focused on emotional lability and problems with self-concept.  The CAARS-INV is a 30 
item version which is completed by the interviewer with cue questions; however, no reliability 
and validity data has been published for this version.   
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 The Childhood Symptom Scale-Self Report Form (ChSS-SRF) created by Barkley and 
Murphy, is an 18 item scale which focuses on DSM-IV criteria, social functioning, oppositional 
defiant disorder (ODD), and conduct disorder (CD) (Rosler et al., 2006).  Time to administer the 
ChSS-SRF is approximately 20 minutes. Reliability and validity are not well established.  
Another tool developed prior to the concept of the DSM-IV criteria is the Brown ADD Rating 
Scale (Brown ADD-RS), which is primarily directed towards symptoms of inattention.  Length 
of the Brown ADD-RS is 40 items, taking only about 15 minutes to administer.  A scale 
specifically designed for children and adolescents, known as the ADHD Rating Scale-IV 
(ADHD-RS-IV), has been studied for the use in adults also.  The ADHD-RS-IV is an informant-
based scaled, consists of 18 items, and takes about eight minutes to administer (Adler & Shaw, 
2011; Rosler et al., 2006).  Another psychometric scale that identifies and assesses five ADHD-
related quality-of -life domains is the Adult ADHD Quality of Life (AAQoL) scale (Adler & 
Shaw, 2011).  Clinicians use the 23 item, self-rated, five point scale to determine the impact of 
ADHD symptomatology and treatment on individuals diagnosed with disorder.   
 In accordance to meeting physician preferences of an adult ADHD screening tool in the 
survey distributed and disseminated by Adler et al. (2009), the rating scale of choice is clearly 
the ASRS v1.1.  The six item scale takes approximately three minutes to administer and was 
developed by a workgroup for adult ADHD (Harvard Medical School, 2005).  The WHO has 
endorsed and validated the ASRS v1.1.  The sensitivity is about 68.7 percent; whereas the 
specificity is an astounding 99.5 percent.  The scale should only be used for assessing and 
screening adults with undiagnosed or diagnosed ADHD (Adler et al., 2009; Harvard Medical 
School, 2005).  A positive screen is not diagnostic of adult ADHD, but absolutely warrants 
further investigation of an adult ADHD diagnosis. Referral to a mental healthcare provider for 
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further diagnostic testing is the appropriate avenue for care of the patient. A negative screen 
would indicate to the provider that an adult ADHD diagnosis is highly unlikely due to the 
specificity of the test, thus the provider should consider other differential diagnoses. 
Social Problems and Comorbidities 
 Individuals with adult ADHD tend to have chronic psychological comorbidities, social 
problems, and substance abuse issues (Knutson & O’Malley, 2009).  Common comorbid 
disorders linked with ADHD include mood disorders, anxiety, and developmental disorders.  
Persons with undiagnosed and untreated ADHD tend to experience low self-esteem; higher rates 
of unemployment, arrests, traffic violations, and divorce; sustain less education; and frequently 
change jobs. Not surprisingly, women with ADHD will become parents at a much younger age 
than their non-ADHD female peer, as well as experience more problems monitoring and 
disciplining their own children. Sexually transmitted infection incidence is fourfold.   Alcohol, 
marijuana, and nicotine abuse are highest among ADHD population as compared to the non-
ADHD individuals smoking is twice as common in the individual with ADHD.  Physiological 
needs of the brain are met for the adult with ADHD because nicotine enhances neurotransmitter 
activity and helps to improve concentration (Knutson & O’Malley).  
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CHAPTER THREE. THEORETICAL FRAMEWORK 
 Healthcare professionals, specifically individuals seeking the Doctor of Nursing Practice 
(DNP) degree, are determined to “positively influence healthcare now and in the future,” 
(Moran, 2014).   One way to positively influence healthcare as a DNP student is to become a 
scholar in one’s area of interest.  The DNP student’s (researcher’s), area of interest is improving 
mental health, thus the topic of adult ADHD was chosen with a focus on improving the screening 
and identification practices of healthcare providers for  adult ADHD.  The focus of the DNP 
discipline concentrates on evidence-based practice (EBP) for improved delivery of care and 
patient outcomes (Burson, 2014).  EBP consists of using current research combined with clinical 
expertise and patient values to formulate appropriate interventions to assist in closing the gap 
between research outcomes and practice (Dontje, 2007).  Use of the Iowa EBP Model may assist 
the DNP scholar with introducing, developing, implementing, and evaluating current EBP in the 
practice setting (Doody & Doody, 2011).   
 Another instrumental component to guiding a scholarly nursing project is by use of a 
theoretical framework.  In general, a theory is considered to be a “notion or an idea that explains 
experience; interprets observation, describes relationships, and project outcomes” (Parker & 
Smith, 2010, p. 7).  A framework is a logical structure that helps the researcher to measure, link, 
and validate outcomes of the project and disseminates findings (Walters, 2011). Therefore, a 
theoretical framework can be utilized to guide the development of a study or project (Grove, 
Burns, & Gray, 2013).  The researcher also chose Everett Rogers’ Diffusion of Innovations 
(DOI) model to guide the dissemination of the project to the providers. Both the Iowa EBP 
model and the DOI model will be overtly discussed.   
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The Iowa Evidenced-Based Practice Model  
 The Iowa model is an algorithm (Appendix B) which represents the process of 
implementing EBP in healthcare (Doody & Doody, 2011).  There are nine steps of the Iowa EBP 
model which utilize a multidisciplinary team approach (Huntington Hospital EBP/NRC Council, 
2013).  Feedback loops are found throughout the algorithm in case specific steps need to be 
repeated.  The model will help guide the entire practice improvement project.  Each step of the 
algorithm will be discussed and applied to the practice improvement project.     
Trigger   
First, the researcher must identify a trigger, which may be a clinical problem or 
knowledge deficit (Huntington Hospital EBP/NRC Council, 2013).  According to a study 
conducted by Adler et al. (2009), a need exists within the primary care community to improve 
education and training in diagnosing and treating adults with ADHD.  Another finding from the 
study includes primary care providers’ willingness to become more involved with diagnosing 
and treating individuals if an easy-to-use, validated tool existed to aid in the screening process.  
The ASRS v1.1 has been validated and takes approximately three minutes to administer (Adler et 
al., 2009; Harvard Medical School, 2005).  A knowledge deficit of adult ADHD and current 
screening practices exists among primary care providers, therefore, establishing a clinical 
problem.  
Organization Priority 
Secondly, the researcher must determine an organization’s priority for the identified 
trigger (Huntington Hospital EBP/NRC Council, 2013).  Is the trigger applicable to the facility?  
Will the facility be supportive?  Will the facility benefit in any way?  After completing an 
interview with a psychologist from the intended small Midwestern facility in rural North Dakota, 
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improving the knowledge and screening process of adult ADHD has been established as 
beneficial to the organization.   
Team Formation  
Following discovery of the trigger and determining an organization’s priority, the 
researcher should then form a multidisciplinary team (Huntington Hospital EBP/NRC Council, 
2013).  Members need to be committed to the change and are responsible for the development, 
implementation, and evaluation of the proposed project (Doody & Doody, 2011; Huntington 
Hospital EBP/NRC Council, 2013).  Committee members were selected based on their 
backgrounds, areas of expertise, and professionalism. Members include: Dr. Dean Gross, PhD, 
FNP-BC, supervisor chair; Dr. Mykell Barnacle, DNP, FNP-BC; Dr. Kevin Ballard, DNP, FNP-
C; Dr. Lisa Montplaisir, PhD, and Dr. Joel Wilson, PhD, MS, BA.  Key personnel established at 
the rural Midwestern facility include a psychologist, chief of medical staff, nursing supervisor, 
participating providers, and support staff.   
Gather Evidence  
Next, the researcher should conduct a relevant literature review (Doody & Doody, 2011; 
Huntington Hospital EBP/NRC Council, 2013).  Information gathered included the history, 
incidence, prevalence, and pathophysiology of ADHD, as well as primary care providers’ 
knowledge and perception of adult ADHD.  Numerous data was also obtained pertaining to 
screening tools used for adult ADHD.  The researcher also interviewed the facility psychologist 
to collect pertinent information for the project.   
Synthesize Evidence 
Once the information has been gathered, the next step is to critique and synthesize the 
evidence (Huntington Hospital EBP/NRC Council, 2013).  Quality, quantity, and consistency 
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should be assessed.  Most data gathered was consistent throughout.  Expert investigators agree 
the ASRS v1.1 is reliable and valid tool, with several resources citing the instrument’s credibility 
(Adler et al., 2009; Adler & Shaw, 2011; Kessler et al., 2005).  A gap in provider knowledge of 
ADHD and current screening practices was found to exist. 
Sufficient Evidence 
Next, the researcher and team members should determine if evidence gathered was 
sufficient to implement the proposed plan of action (Huntington Hospital EBP/NRC Council, 
2013). This step was accomplished by conferring with the committee members during the project 
proposal meeting.  Suggested changes from feedback received was applied to the improve 
project outcomes.   
Pilot the Change  
The following step is to determine the outcomes to be achieved and implement the EBP 
project idea (Huntington Hospital EBP/NRC Council, 2013).  The projective objectives were to 
1.) Improve the screening and identification of adults with undiagnosed ADHD for appropriate 
referral and treatment using the ASRS v1.1 and 2.) Enhance healthcare professionals’ awareness 
and education of adult ADHD.  The strategies used to accomplish the objectives are explained 
under the project design section of the paper.  
Evaluation 
After piloting the proposed project, the researcher analyzed the collected data and 
determined if there was an improvement in quality of care and patient outcomes (Doody & 
Doody, 2011; Huntington Hospital EBP/NRC Council, 2013).  Evaluation was accomplished 
through an interview with the facility psychologist as well as by having healthcare providers 
complete a voluntary survey using a Likert scale format (Appendix C).  
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Implementation 
If the intervention was found to improve care, full implementation within the 
organization can occur with continued monitoring (Huntington Hospital EBP/NRC Council, 
2013).  Intentions of the researcher were to have the ASRS v1.1 integrated into the electronic 
medical record.  As previously explained, providers should screen individuals displaying signs 
and symptoms of inattention, impulsivity, hyperactivity, depression, anxiety, substance abuse, 
and frequent job changing in the primary care setting (Adler & Shaw, 2011).   
Dissemination of Results 
Lastly, the researcher should disseminate the results of the practice improvement project 
(Huntington Hospital EBP/NRC Council, 2013).  Dissemination of results will occur through the 
researcher’s dissertation report and final committee meeting.  Stakeholders from the intended 
facility will be informed via electronic (e-mail) and/or during a brief in-service.  A poster 
presentation will additionally be completed at North Dakota State University. Other hopes are to 
publish findings in a scholarly, peer-reviewed journal.   
Summary 
The Iowa EBP model is an easy-to-follow algorithm which assisted the researcher to 
conduct, implement, and convey results of the practice improvement project.  Emphasis is placed 
on the importance of having a multidisciplinary team to facilitate the project.  Project success is 
attainable with the help of the model.  
Diffusion of Innovations Model  
 History demonstrates the need for the use of the DOI model because such a large gap 
exists between proven concepts of health and implementation into practice (Oldenburg & Glanz, 
2008).  The focus of the DOI model was to guide the researcher with the implementation of the 
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practice improvement project.  The framework of the DOI model “enables one to understand the 
process of innovations and the various stages involved in the adopting a new idea, thereby 
narrowing the gap between what is known and what is put to use” (Pender, Murdaugh, & 
Parsons, 2011, p. 76).  The researcher recognizes a knowledge-practice gap between healthcare 
providers and identification of adult ADHD.   
Diffusion 
Diffusion is the overall spread of an innovation, by communication of certain channels, 
among members of a social system over time (Oldenburg et al., 2011).  As demonstrated by the 
definition of diffusion, four main components exist: innovation, communication channels, time, 
and a social system (Pender et al., 2011).  An innovation is defined as an idea, practice, or object 
that is perceived as new by an individual or organization (Oldenburg et al., 2008).  The 
innovation for this practice improvement project is the ASRS v1.1 implementation in the primary 
care setting for purposes of screening and identifying adults with ADHD.  Communication 
channels are the means by which a message, or innovation, is spread.  Channels of 
communication include mass media, electronic communications, and interpersonal interactions.   
The researcher notified healthcare professionals of adult ADHD education and implementation 
of the ASRS v1.1 at a formal facility meeting as well as via e-mail.  Interpersonal interactions 
were also utilized, as the researcher was conveniently on site from time to time.  For the purpose 
of the DOI model, a social system is defined as a set of individuals engaged in joint problem 
solving to accomplish a common goal.  The social system for this practice improvement project 
is made up of the clinical dissertation committee and healthcare professionals of a small, 
Midwestern facility in rural North Dakota.   
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Spread of Diffusion 
The spread of diffusion is on a continuum, with one end of the spectrum considered to be 
passive, while the opposite end is active diffusion (Oldenburg et al, 2008).  Passive diffusion is 
more unintentional or informal spread of innovations by peers and social networks.  Active 
diffusion is the spread of an idea purposefully and formally, utilizing vertical hierarchies.  Three 
general pathways exist in which innovations can be disseminated actively.  The first is “direct to 
practice” distribution of materials and tools.  A second pathway is the implementation of 
policies, legislation, and regulations.  Thirdly, the last pathway is a systematic long approach that 
utilizes multiple strategies and methods, and has ongoing evaluations over time.  The researcher 
chose to execute the “direct to practice” approach by implementing the adult ASRS v1.1 tool in 
the primary care setting.   
Stages of Diffusion 
There are numerous stages in the diffusion process.  The first stage of diffusion is 
innovation development, followed by dissemination, adoption, implementation, maintenance, 
sustainability, and institutionalization (Oldenburg et al., 2008).  Typically, the innovation 
development stage utilizes a social marketing scheme to implement the idea.  Dissemination 
requires persuasion of the target audience to adopt the intended innovation.  Innovation 
development and dissemination of this project was accomplished by e-mailing healthcare 
professionals about the key points of adult ADHD and use of the ASRS v1.1 as well as 
introducing the practice improvement project at a facility meeting.  Advantages of using the 
ASRS v1.1 were explained to persuade the healthcare professionals to utilize the suggested scale.  
The adoption stage is the core of the DOI process and will be discussed further in the next 
section.  A key component of the adoption stage is the target adopters.  Target adopters involved 
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in the project include healthcare professionals in the primary care setting of the intended facility.   
Before implementing a project, the target adopters’ needs should be addressed and current 
attitudes, values, and beliefs should be evaluated.  Assessing the aforementioned components of 
the target adopters determines the success of the diffusion process.  Potential problems that may 
be encountered during the implementation stage should be considered.  Resources and support 
should be sought to help execute the innovation dissemination.  The maintenance and 
sustainability stages involve the continued use and improvement of the intended program.  
Institutionalization is the final stage and pertains to the organization, community, or setting 
where the diffusion of the innovation will take place.  Plans to implement the ASRS v1.1 will 
take place in a small, Midwestern regional facility in rural North Dakota.  Committee members 
were helpful in assisting with the identification of potential problems encountered during the 
implementation stage.  Other resources and support are more broadly discussed in the project 
design section of the paper.  
Adoption   
The speed of which adoption of the innovation will occur is dependent on a number of 
characteristics (Oldenburg et al., 2008; Pender et al., 2011).  Characteristics include relative 
advantage, compatibility, complexity, trialability, and observability.  Each characteristic will be 
defined separately. Relative advantage involves the adopter’s perception of the innovation.  The 
innovation must be perceived as better than the current idea (Pender et al., 2011).  The 
innovation must fit with the adopter’s attitudes, values, and beliefs for compatibility to exist 
(Oldenburg et al., 2008). Ease of use and a lesser complexity of the innovation must exist for 
successful implementation. The ASRS v1.1 is a six item scale adopted by the WHO, which takes 
approximately three minutes to administer, quickly allowing the healthcare professional to 
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identify an individual with the potential for adult ADHD (Adler et al., 2009; Harvard Medical 
School, 2005). The adopter should have to opportunity to experiment with the innovation for 
trialability to be present (Oldenburg et al., 2008).  Healthcare professionals should have been 
able to easily experiment with the scale as it was readily available and easy to access within the 
facility.  Observability is the degree of which the benefits of the innovations are visible to others.  
All characteristics are essential components of the DOI model; however, relative advantage may 
be the most notable predictor of the rate of adoption.  The researcher tried to convey the 
innovation’s advantages clearly and obviously.  
Types of Adopters 
The degree of which individuals, organizations, or communities adopt new ideas is 
referred to as innovativeness (Pender et al., 2011).  Five types of adopters exist among the 
population: innovators, early adopters, early majority, late majority, and laggards.  Innovators are 
individuals actively seeking information and are not easily affected by high levels of uncertainty 
or change.  Innovators are risk takers and are first to adopt a new idea.  Early adopters tend to 
have a very valued opinion among peers and are checked with before others will adopt the idea.  
The early majority adopters are very concise in the decision to adopt the idea.  Skepticism and 
pressure from peers increases the late majority type to adopt the innovation.  Laggards are 
always the last to adopt the idea, if at all.  Laggards are suspicious and often avoid change. 
Adopting the idea is a last resort for the laggards.  The researcher was cognizant of the fact that 
individuals or organizations will adopt ideas at different paces.  Importance was placed on the 
identification of the early adopters, as these individuals will facilitate change the quickest.  It was 
an obvious advantage to persuade active committee members to help facilitate change and 
implement the adult ASRS v1.1 instrument.   
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Summary 
 Key components of the DOI model include characteristics influencing the speed of 
adoption and categories of adopters.  The researcher needed to be especially clear and concise 
about the innovation to achieve maximum relative advantage. Identification of the early adopters 
was essential to the diffusion process of the ASRS v1.1.   
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CHAPTER FOUR. PROJECT DESCRIPTION 
 A Midwestern regional healthcare facility located in rural North Dakota does not have an 
efficient and effective way to screen adults for ADHD (J. R. Wilson, personal communication, 
April 4th, 2014).  There is not a consistent adult ADHD screening process in place.  An adult 
ADHD screening tool for primary care providers would be useful to determine the appropriate 
course of care for patients.   The adult ASRS v1.1 screener can be used similarly to the Patient 
Health Questionnaire (PHQ-9) and Generalized Anxiety Disorder (GAD-7) when individuals 
have suspected symptoms or complaints of inattention, hyperactivity, impulsivity, depression, 
anxiety, and consistent substance abuse patterns (Adler & Shaw, 2011; J. R. Wilson, personal 
communication, April 4th, 2014).  Individuals consistently meeting four or more criteria using 
the ASRS v1.1 warrant a positive screen (Harvard Medical School, 2005).  A trained clinician 
should follow-up with individuals screening positive.  A referral to a psychologist or psychiatrist 
is appropriate (Pearson & Crowley, 2012).   
The overall goal in healthcare is to improve individuals’ quality of life (J. R. Wilson, 
personal communication, April 4th, 2014).   By improving healthcare professionals’ knowledge 
of adult ADHD and utilizing the ASRS v1.1 tool, the process of screening and identifying adults 
with undiagnosed ADHD should become more efficacious.  Improving the screening process 
will allow individuals with undiagnosed ADHD to receive the appropriate treatment and improve 
overall quality of life.  
Project Objectives 
 Healthcare providers/professionals are instrumental in the process of identifying adults 
with ADHD.  Individuals with complaints of anxiety, depression, inattention, hyperactivity, 
impulsivity, frequently changing jobs, or problems with substance abuse should be screened for 
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ADHD (Adler & Shaw, 2011; APA, 2013; DuPaul et al., 2011).  By increasing healthcare 
professionals’ awareness of signs and symptoms of adult ADHD and the six question adult 
ASRS v1.1, improvement in adult ADHD identification should result.  Implementation of the 
ASRS v1.1 in the primary care setting will achieve the following objectives: 1.) Improve the 
screening and identification of adults with ADHD for appropriate referral and treatment and 2.) 
Enhance healthcare professionals’ education and awareness of adult ADHD.   
Project Design 
Patients with ADHD can present with a wide variety of diverse symptoms (Buitelaar et 
al., 2011).  Individuals will likely have complaints related to decreased concentration or focus, 
such as difficulty starting a project, forgetfulness, cloudy thinking, and distractibility.  
Hyperactive symptoms may not be as obvious.  Individuals may express the need to be 
ambitious, keep busy, or have difficulty sitting still in long meetings or presentations.  Other 
complaints may be related to chronic conflict in relationships with family members, significant 
others, peers, and/or authority figures.  Furthermore, a detailed history may reveal family 
members with ADHD; difficulties with substance abuse; mood disorders; poor performances at 
work; struggles with academics; and lastly, frequent traffic violations or automobile accidents.  
The healthcare professional should keep in mind individuals with the aforementioned complaints 
may not have ADHD, but certainly need to be screened.   
Identifying adults with ADHD can be a complex task, as the presentation of this disorder 
varies extensively (Buitelaar et al., 2011).  Healthcare professionals have limited time with 
patients and distinguishing between mental health disorders can be a difficult and consuming.  
There is a need to increase provider awareness of adult ADHD presenting symptoms, as well as 
implementing more consistent screening for the disorder.   
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Execution of the project took place at a small, Midwestern regional facility in rural North 
Dakota.  The site was chosen based on location and convenience for the researcher; support and 
easy contact with healthcare providers; and identified need to improve the screening and 
identification process of adults potentially undiagnosed with adult ADHD.  Initiation for use of 
the adult ASRS v1.1 began on July 31st and concluded on December 31st, 2014.  The evaluation 
process was completed thereafter; in which healthcare providers voluntarily completed a form 
and returned to the researcher via postal mail services pertaining to ease of use of the tool and 
benefit to clinical practice. Completion time of the post-evaluation survey by healthcare 
providers was estimated to be about 10 to 15 minutes.  Time frame allotted to voluntarily 
complete the survey in regards to evaluation of the tool was approximately four weeks, from 
January 5th to January 29th, due to busy schedules and absences (Appendix C).    
Introduction of the project, as well as proper use of the adult ASRS v1.1, was explained 
during a facility meeting to primary care providers prior to the initiation date by the co-
investigator.  All questions were answered and voluntary participation was emphasized.   
Healthcare professionals, which included primary care providers and nurses, were also notified 
via e-mail in regards to implementation and instruction of the screener prior to initiation of the 
project (Appendices D & E).  Bright green binders were placed at each nursing station with 
explicit instructions; factual information about adult ADHD; copies of the ASRS v1.1; and 
participant consent forms (Appendices F, G, H, I, J).  If patients chose to participate in the 
project, a member of the healthcare team made a copy of the completed ASRS v1.1 to be kept for 
data collection and returned it to the green binder in a designated green folder.  Only patient age, 
sex, and if he or she was referred to psychology was noted in the upper right hand corner of the 
screener (Appendix H).  No other identifying data was collected.   Recommendations to refer a 
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patient to appropriate services are warranted when a positive score of the ASRS v1.1 is 
identified.   
Project Resources 
  In order to complete the project, several resources were necessary.  Resources utilized 
include support and approval from personnel and organizations, healthcare personnel, time 
commitments, technology, and lastly, a minimal amount of money.  Two organizations the 
researcher sought approval from included the WHO and the University of Iowa Hospital and 
Clinics.  Approval from the WHO to utilize and implement the ASRS v1.1 for the purposes of a 
dissertation project was obtained via e-mail (Appendix K).  Dr. Ronald Kessler, leader of an 
expert adult ADHD committee, additionally provided approval and support for use of the ASRS 
v1.1 (Appendix L).  The University of Iowa Hospital and Clinics provided permission to use the 
Iowa EBP model algorithm to guide the project and site within the dissertation (Appendix M). 
Furthermore, Dr. Marita Titler, creator of the Iowa EBP algorithm, provided permission via e-
mail.  Prior to beginning the project, Institutional Review Board (IRB) approval was obtained 
from North Dakota State University (NDSU) as well as the rural Midwestern facility’s IRB 
(Appendices N & O).   
Personnel involved include the researcher, clinical dissertation committee members, 
healthcare professionals (providers and nurses), and appropriately identified patients willing to 
participate in the project.  Key personnel included the facility psychologist; the chief of medical 
staff physician; and the nursing supervisor.  Each individual was instrumental to the facilitation 
of the project.  The psychologist, Dr. Joel Wilson; was frequently consulted by the researcher 
and healthcare providers in regards to the project.  Dr. David Muhs, department lead, played a 
vital role in the process, as he provided permission for the researcher to introduce project 
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materials at a provider meeting as well as forwarded e-mails with instructions to the appropriate 
individuals (Appendix D).  The lead nurse conferred with the researcher on several occasions in 
regards to disbursement of materials and security of confidential information. She physically 
placed binders at each nurses’ station; forwarded e-mails to appropriate staff about 
implementation of the project (Appendix E); and introduced the project and what role the nurses 
will play at a meeting. 
Time is vital when implementing a scholarly project.  Time commitments were most 
substantial for the researcher and dissertation committee members; however, the project would 
not have been completed without time commitments from all personnel involved.  Certain 
training for IRB approval, known as the Collaborative Institutional Training Initiative (CITI), 
took several hours for the principal investigator and co-investigator (the researcher) to complete 
prior to obtaining approval (Appendix P).  IRB approval from the governing bodies took days to 
weeks to acquire.  Throughout the project, several IRB addendums from the governing bodies 
were necessary (Appendix Q & R).  
Individuals previously mentioned volunteered their time to participate in the project.  
Execution of the ASRS v1.1 would not have been established without the aforementioned 
individuals.  Extra time during clinic visits was also taken to explain and complete the Adult 
ASRS v1.1on the part of the healthcare professional and patient.  A three minute time frame was 
estimated for the aforementioned process. The researcher (co-investigator) was responsible for 
closely following the project, e-mailing the healthcare professionals, updating committee 
members, and lastly, completing the final dissertation report.  The dissertation committee 
members, especially the chair person and expert committee member, spent extensive time 
assisting in research, development, implementation, and evaluation of the proposed project.  
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 Technological resources necessary for implementation of the practice improvement 
project included computers, internet access, electronic mail, and cellular devices.  The researcher 
e-mailed healthcare professionals prior to implementation of the project as well periodically 
thereafter for project reminders (Appendices D, E, & S). Communication between the co-
investigator and principal investigator was necessary throughout the process and most often 
occurred via e-mail.   
 Funding for the project was relatively insignificant.  The only identifiable cost 
established was the cost of the green binders, green folders; and ink cartridges necessary to print 
the ASRS v1.1, consent forms, written instructions, and ADHD facts (Appendices H, I, J, F, & 
G).  The researcher personally funded the aforementioned materials.  The rural Midwestern 
facility charged no fees for implementation of the project.  All personnel involved with the 
project did so strictly on a volunteer basis.  No momentary rewards were provided to anyone 
participating in the project.  
Protection of Human Subjects 
 The human subjects involved in the project encompassed healthcare professionals, 
including primary care providers, nurses, and a psychologist; and adults being screened for 
ADHD.  For the purposes of this project, no special precautions were taken to include or exclude 
women and minorities.  Patients were chosen if he or she met the following qualifications: 18 
years or older; no diagnosis of ADHD; and displaying signs and symptoms which could 
potentially indicate adult ADHD.  No children were involved in the project as a substantially 
different established screening and identification process for ADHD is established.  
The practice improvement project indirectly involved patients by implementation of the 
ASRS v1.1 tool by primary care providers and nurses; therefore little to no risk to patients was 
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established.  Patients may have potentially experienced some psychological distress when the 
ASRS v1.1 was administered.  More anguish could have resulted if the patient’s score was 
positive and was referred to a specialist for further diagnostic testing.  Healthcare professionals 
also may have encountered psychological distress in relationship to being given an additional 
workload.   
 Protection of human subjects was ensured by the North Dakota State University IRB as 
well the intended facility’s IRB (Appendices N & O).  The healthcare participants were specific 
to the designated rural Midwestern facility.  Contact between the researcher and healthcare 
participants existed in person and via e-mail.  Participation was voluntary as evidenced by 
informed consent, emphasis of voluntary involvement, and implementation per choice of the 
provider and/or nurses.  Completion of the evaluation survey to be filled out by the healthcare 
participants was unquestionably voluntary.  The patient population chosen to partake in the 
project was a convenience sample of adults in primary care demonstrating signs and symptoms 
of ADHD based on provider discretion.  
  The intended benefits of the project included improvement in the screening and 
identification of adults with ADHD, increased knowledge of adult ADHD among healthcare 
providers, and overall improvement in the quality-of-life of individuals with undiagnosed and 
untreated adult ADHD.  Other healthcare facilities in the region may choose to implement the 
scale based on the, further improving adult ADHD identification.  By improving the screening 
process and identification of adult ADHD, individuals can receive necessary treatment.  
Reduction of comorbid conditions and chronic diseases may occur as a result; thus improving 
one’s quality of life.   
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Methods 
 As previously mentioned by Dr. Joel Wilson (personal communication, April 4th, 2014), 
the intended facility does not have an efficient, consistent, nor an effective way to screen adults 
for ADHD. An adult ADHD screening tool for primary care providers would be useful to assist 
in the process of determining the appropriate course of care for patients.  Prior to the project, 
providers at the intended facility were frequently consulting with the psychologist and potentially 
missing individuals with undiagnosed ADHD.  The adult ASRS v1.1 is a 6 item, well-
recognized, screening tool created by ADHD experts and copyrighted by the WHO (Harvard 
Medical School, 2005).   Individuals presenting to primary care with signs or symptoms of 
inattention, hyperactivity, impulsivity, depression, anxiety, or consistent substance abuse patterns 
without a diagnosis of ADHD should be screened (Adler & Shaw, 2011; J. R. Wilson, personal 
communication, April 4th, 2014).  Permission was granted by the WHO and Dr. Ronald Kessler 
to use the adult ASRS v1.1 for the project via e-mail (Appendices K & L).   
 In order to establish the most convenient way to implement the ASRS v1.1 and reduce 
workload of the project for the volunteers, the researcher consulted with the involved 
psychologist at the facility and the supervising nurse on several occasions.  A decision was made 
to have binders containing copies of the ASRS v1.1, consent form, and other pertinent resources 
at each nurses’ station.  A bright green color theme was established for binders and folders as 
this may have helped proliferate project awareness and institute consistency.  Healthcare 
providers and nurses were given project information in numerous formats.  First, the co-
investigator attended a facility meeting to introduce the project idea to the healthcare providers.  
E-mails were sent to healthcare providers and nurses prior to launching the project as well as 
thereafter to remind the healthcare professionals about the ASRS v1.1 (Appendices D, E, & S).  
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Appropriate use and instruction of the ASRS v1.1 was also provided within the bright green 
binder on the first page (Appendix G).   
 Healthcare professionals were instructed to administer to the ASRS v1.1 to adult patients 
presenting to primary care for a wellness or episodic visit displaying signs and/or symptoms of 
substance abuse; anxiety; depression; inattention; hyperactivity; impulsivity; frequently changing 
jobs; and no current ADHD diagnosis.  The project coordinator checked the green binders for 
completed forms periodically, ranging from weekly to monthly.  After several weeks of the 
initiation of the project, only a few forms were collected; thus, the researcher sent our reminder 
e-mails to the healthcare professionals (Appendix S).   IRB addendum approvals from NDSU 
and the established facility were received (Appendix Q & R).   
 As stated before, data was collected throughout the implementation of the project at 
weekly to monthly intervals.  The implementation of the ASRS v1.1 began July 31st, 2014 and 
ceased December 31, 2014.  A voluntary survey evaluation of the ASRS v1.1 was delivered to 
providers.  Those who chose to participate returned the evaluation via postal mail within four 
weeks.  Data examination of the completed screeners and evaluation surveys were analyzed by 
the co-investigator.   
Evaluation 
 The overall goal of the project was to meet the two designated objectives of 1) increasing 
the screening and identification of adults with undiagnosed ADHD for appropriate referral and 
treatment; and 2) improve healthcare professionals’ education of adult ADHD.  By execution of 
the adult ASRS v1.1 and evaluation of the screener in the Midwestern regional facility, both 
quantitative and qualitative data were able to be collected for appraisal of the project objectives.  
Key quantitative components of the ASRS v1.1 assessed include number of participants; patient 
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demographics comprising age and sex; number of negative or positive screens; and lastly, 
whether or not the patient was referred.  Quantitative and qualitative analysis of the ASRS v1.1 
and project was also conducted.  Qualitative data gathered included an interview with the 
psychologist on the project process and open-ended questions answered on the evaluation 
survey.  A Likert scale format was also included on the evaluation form; thus establishing an 
additional quantitative format to gather data.  Imaginably, another excellent way to estimate the 
success of the project would be whether or not the Midwestern regional facility chose to 
consistently administer the ASRS v1.1 to appropriate patients.   
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CHAPTER FIVE. RESULTS 
 Implementation of the ASRS v1.1 was initiated July 31st, 2014 and concluded on 
December 31st, 2014 at a rural Midwestern North Dakota facility.  The patient population 
included adults only.  The total number of patient participants was 24.  Of the 24 participants, 
four were screened by a psychologist and not a primary care provider; thus these data were not 
included in the overall results; however, analysis was still performed and may be considered 
beneficial.  Twenty of the 24 participants were screened in primary care.  No information was 
gathered on the number of patient participants refusing to be included in the study. The entirety 
of positive screens substantiated was 16.  Of the 16 positive screens, only three were documented 
on the screener as referred; however, it is unknown if more patients were actually referred for 
additional evaluation.   
 Healthcare providers choosing to participate in the study totaled six; with a potential for 
thirteen.  Additionally, the psychologist also participated in the study.  Seven survey evaluations 
were distributed to providers with a return rate of five.   
Sample Demographics and Data Analysis 
 Patients screened in primary care had the following demographics:  the age of the patient 
participants ranged from 18 to 81, with a median age of 25; average age of 28; and mode of 18.   
The total number of male participants was 12, while the female sum was 8.  Two of the three 
patients documented as referred for further care were female.   
 Data analysis of patient participants screened by the psychologist is summarized. The 
additional data could provide further insight to the project.   The ages of the participants ranged 
from 18 to 53, with a median, average, and mode age of 34.  Two of the four participants were 
female; whereas the other two were male.  All screens were documented as positive.  Individuals 
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were initially referred for either depression, further assessment, or other “mental problem”.  This 
information was documented in the upper right hand corner of the ASRS v1.1.    
 The sample population for healthcare providers included a potential of thirteen.  Based on 
collected forms from the binders at the designated nurses’ station only six primary care providers 
and/or healthcare professionals chose to or were able participate.  It is assumed support staff, 
such as nurses also assisted in the process.   
Data Results 
 To reiterate, the project objectives included 1) increasing the screening and identification 
of adults with undiagnosed ADHD for appropriate referral and treatment; and 2) improving 
healthcare professionals’ education of adult ADHD.  No quantifiable data were gathered in 
regards to the project objectives because prior numerical information of the facility’s 
identification of adult ADHD did not exist.  Overall, the assessable results are qualitative.  To 
recall, Dr. Joel Wilson determined a facility need to create a more efficient, consistent, and 
effective way to screen adults for ADHD in primary care (personal communication, April 4, 
2014).  Based on an additional interview with Dr. Wilson, he subjectively felt that he has 
received more referrals since implementation of the practice improvement project (personal 
communication, January 20th, 2015).  He additionally felt that all referrals received were 
appropriate and not falsely identified based on the ASRS v1.1.  Acknowledgement of the lack of 
pursuit of an adult ADHD diagnosis in the past at the established facility was identified.  Dr. 
Wilson felt strongly that the tool was advantageous, demonstrating clarity for the primary care 
providers in regards to the referral process.  When reflecting back on the referrals he received, 
the college age patient prominently stood out in his mind as the individual with undiagnosed 
ADHD distinctly struggling.  Comments he received throughout the project from providers were 
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all positive and related to the ease and efficiency of the tool; clarity of the mental health 
problem; and the helpfulness of justifying a referral.  Based on the interview, both projective 
objectives were met.   
 Next, results of the five completed evaluation surveys completed by providers will be 
given.  Of the five surveys, none were entirely answered.  Four of the five surveys had some of 
the open-ended questions completed and all five had the Likert section finished.  First, the 
quantitative data will be provided.  A four-point Likert scale was created, with response choices 
of strongly disagree, disagree, agree, and strongly agree. A total of four questions were asked.  
The answers to the Likert scale are given below: 
Statement One 
The ASRS v1.1 is easy to use. This statement was created with the intention to establish 
practicality of the instrument.  All responders agreed, with four of the five strongly agreeing with 
the statement.  
Statement Two 
The ASRS v1.1 is quick to administer. Similarly to statement one, this question was 
developed to evaluate efficiency of the tool.  Again, every response was documented as agreed, 
with four out five feeling strongly.  
Statement Three 
The ASRS v1.1 has been helpful in distinguishing between different comorbid psychiatric 
disorders. The purpose of statement three is an attempt to distinguish adults with ADHD whom 
present with anxiety, depression, addictive behaviors, or other common psychiatric disorders.  
Two of the five replies indicated a strongly agreed answer.  Additionally, two other responders 
agreed with the statement.  The last individual disagreed.   
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Statement Four 
Implementing the ASRS v1.1 has improved my knowledge in regards to adult ADHD. 
Question four helps to demonstrate the objective of improving healthcare professional’s 
knowledge of adult ADHD was met.  Two providers felt strongly this statement was accurate 
based on their experience, whereas one response simply agreed.  The final two responses 
indicated an “X” in the disagree column.   
 Next the qualitative data from the evaluation survey is provided.  To reiterate, this section 
of the survey was not entirely completed by the providers. Some questions were left blank, while 
other questions had helpful feedback. 
Question Five 
What did you like about the ASRS v1.1? Intention of this question was to establish 
benefits of the screener.  Providers choosing to answer the question felt the tool was simple, 
efficient, and appreciated the standardized questions.  One provider also mentioned the tool’s 
helpfulness in determining a referral to psychology for testing.  Only one evaluation did not 
produce a response to this question.  
Question Six 
What didn’t you like about the ASRS v1.1? The purpose of this question of was to identify 
barriers based on provider responses. Two providers felt that the tool could be “figured out” by 
the patient for purposes of faking results.  Additionally, one of these responses included a 
comment establishing that further diagnostic testing would address the potential issue.  One 
provider found no barriers of the tool; while the remaining two providers did not answer the 
question.   
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Question Seven 
What would you like to see done differently in screening individuals with the potential for 
adult ADHD? This question was included to provide recommendations for future projects and 
additional information for improvements in the screening and identification of adults with 
ADHD.  Only one evaluation had a documented response to the question in which it was stated 
to “continue to emphasize benefits of screening, similarly to PHQ-9 and GAD-7, to improve 
patient care.” 
Question Eight 
What information about adult ADHD would you like to know more about? Pertinence of 
question eight was to establish educational needs of providers in regards to adult ADHD.   Two 
of the five providers responded to the eighth question.  One response pertained to more 
knowledge about medications for treating adults with ADHD as well as the risk for abuse of the 
medications prescribed.  The other provider also documented the desire to learn more about 
treatment options.  Furthermore, the provider was interested in knowing the likelihood of a new 
ADHD diagnosis in patients who were previously diagnosed as children.   
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CHAPTER SIX. DISCUSSION AND RECOMMENDATIONS 
 The greatest cause of disability in the United States is mental health disorders (Healthy 
People 2020, 2013).  Untreated mental health disorders frequently lead to high risk behaviors, 
such as drug and illicit alcohol abuse; violent or self-destructive behavior, and/or suicide.  
Among children, ADHD is the utmost collectively diagnosed mental disorder (Ryan, 
Katsiyannis, & Hughes, 2011). Prior beliefs were that children outgrew the disorder preceding 
adulthood; however, a more recent concept is that ADHD is problematic in adulthood as well 
(Boonstra, 2006; Dalsgaard, Østergaard, Leckman, Mortensen, & Pedersen, 2015; McGough & 
Barkley, 2004).  Research has identified that adult ADHD is persistently misjudged and not well 
understood as compared to other comorbid mental health disorders, such as anxiety and 
depression, by primary care providers (NACE, n.d.).  Consequently, individuals with 
undiagnosed ADHD do not receive proper medical care and treatment; thus eliminating the 
ability to achieve one’s maximum capacity as a member of society.  A goal of Healthy People 
2020 (2013) is to increase the proportion of adults with mental health disorders who receive 
treatment.  Both objectives of this project were applicable to Healthy People 2020 above-
mentioned goal.  By improving screening and identification of adults with undiagnosed ADHD, 
the likelihood of receiving proper treatment should be amplified.  Correspondingly, enlightening 
healthcare provider’s knowledge of ADHD ought to assist in the screening, identification, and 
treatment of individuals who currently remained undiagnosed with ADHD.  
Qualitative Results and Interpretation 
Secondary to a small sample size, statistics of the study are not relevant or appropriate; 
however, much of the qualitative information gathered was still distinguished as valid.  Of the 
qualitative data, several trends were discovered which could be deemed beneficial.  According to 
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the qualitative data provided by Dr. Wilson, an enhancement in the screening process for adults 
with undiagnosed ADHD was achieved.  He subjectively noted an increase in the amount of 
patients he was seeing to be further evaluated for adult ADHD.  All referrals he received in 
which the ASRS v1.1 was instituted were concluded to be appropriate.  He distinguished the tool 
as exceptionally valuable and affording simplicity to primary care providers.  Numerous 
comments he received related to the straightforwardness, efficiency, and precision of the ASRS 
v1.1.  As for the answers provided in the evaluation survey completed by the providers; a 
consensus of the effortlessness, efficacy, and standardization of questions seemed to be 
appreciated.  Two providers felt a barrier of the tool is that patients could replicate a positive 
result due to the face validity of the tool; however, one individual ultimately felt that further 
testing could eliminate the potentially identified problem.  Two providers confessed that having 
more knowledge pertaining to the best treatment options for adults and associated risks with use 
of medication would be advantageous.  To further improve the process in the future, one 
provider indicated that continual emphasis of the screener may be helpful.   
Quantitative Results and Interpretation 
 The total number of patient participants screened in the primary care setting was 20, with 
a male to female ratio of 3:2.  The average age of the patient was 28; a median age of 25; and 
lastly, a mode of 18. Of the 20 patients screened, 16 received a positive score; however, only 
three of these patients were documented as referred for further care.  Two of the three patients 
documented as referred were female.  Several inferences from these results can be made.  One 
could speculate since 80 percent of the patients screened were positive, providers are likely 
cognizant of individuals at risk for adult ADHD, but may have simply needed a screening tool to 
validate a referral or to make the process easier.  Other inferences include the idea that possibly, 
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more males than females display signs and symptoms of ADHD; or, males more predominately 
have the disorder, which would be consistent with the literature review conducted for the study.  
Another extrapolation from these results may be that individuals in their mid-twenties display the 
most signs and symptoms of ADHD; are diagnosed most commonly in their twenties; or seek 
care more frequently.  Additionally, to recall, 16 of the 20 participants screened received a 
positive score; which may indicate that providers were not screening appropriately prior to being 
made aware that ADHD was a significant issue or is commonly missed. Another idea to consider 
is that the screening is still not completed enough based on such a high positive response rate. 
One can conclude that the tool significantly assisted in the screening process.  Ultimately, 
individuals should be receiving further testing and proper care as a result.  
 Although the project had no intentions of gathering data in a specialty; four additional 
ASRS v1.1 were obtained from the facility’s psychologist.  All screens were positive and the 
male to female ratio was 1:1.  The patients were referred from primary for further assessment of 
mental health disorders.  The average, median, and mode age of the patients was 34.  
Insinuations from these results primarily indicate that patients with mental health disorders could 
benefit from the ASRS v1.1 screener in primary care.    
Advanced Practice Nursing Implications 
 The following section will discuss implications for the future and current advanced 
nursing practice.  The two objectives of the project will be restated and the researcher will 
explain appropriate applications.  As state previously, a goal of Healthy People 2020 (2013) is to 
increase the proportion of adults with mental health disorders who receive treatment.  Advanced 
practice nurses, as well as other members of the healthcare team should work together to help 
achieve the aims of Healthy People 2020.   
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Objective One 
 The first intention of the project was to improve the screening and identification of adults 
with undiagnosed ADHD for appropriate referral and treatment utilizing the ASRS v1.1.  
According to subjective information provided by the active psychologist in the project, this goal 
was met.  From the initiation date of July 31st, 2014 to the end date of December 31st, 2014; he 
noted an increase in referrals for adults who needed further ADHD testing; however, no 
quantifiable data was gathered to establish this statement.  All healthcare providers opting to 
participate in the study felt the tool was beneficial, improving the simplicity and efficiency of the 
ADHD screening process.  Implementing a basic and valid tool in primary care to screen for a 
mental health disorder consequently assists in the identification of patients with undiagnosed 
psychological disorders.  Thus, appropriate treatment and improvement in one’s quality of life 
should result.   
Objective Two 
 A second purpose of the practice improvement project was to enhance provider 
knowledge of adult ADHD, with hopes of ultimately augmenting the screening, identification, 
and treatments of undiagnosed adult ADHD patients.  Based on the quantitative and qualitative 
data obtained from the project, the goal was met.  Three of the five provider responses on the 
evaluation survey indicated an improvement in their adult ADHD knowledge since 
commencement of the project.  Two of the five did not recognize an enrichment of knowledge on 
the topic. The researcher recognizes a discrepancy in the disagreement responses.  Upon 
reflection of the project, no primary care providers were aware of the ASRS v1.1; therefore all 
providers’ knowledge of adult ADHD was ultimately improved.  By introducing a simple and 
valid tool to unknowing providers, enriched care of patients with mental health disorders results.  
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Subsequently, reduction in comorbid chronic diseases, such as diabetes, heart disease, and cancer 
is an implied expected outcome, as untreated mental health disorders negatively impact one’s 
physical health (Healthy People 2020, 2013).   
Project Limitations and Recommendations for Future Research 
 Limitations of the project will now be discussed.  An obvious inadequacy of the project is 
the small sample size.  To achieve the best sample size for the population, the researcher should 
have configured this prior to initiation of the project (McClave & Sincich, 2013). The 
Midwestern regional facility in which the study took place only had a total of 13 primary care 
providers, and only six chose to participate in the study; accordingly limiting the patient 
participation sample size.  Reasons some providers chose not to participate could be because 
they were not well solicited by the researcher. Additionally, potential explanations include 
additional workload; lack of patient population displaying signs or symptoms of ADHD; 
disinterest or disbelief in adult ADHD; or absence of awareness of the project.  Lastly, thinking 
back to the DOI model, having only about half of the providers participate could be contributed 
to individuals whom are innovators or early adopters versus late adopters or the laggards. 
 Another constraint of the study may have been the placement of the green binders which 
contained copies of the ASRS v1.1.  The binders were located at each nurses’ station during the 
project.  A potential improvement could be placing a binder in every exam room for convenience 
and a reminder to screen appropriate patients.  Having the ASRS v1.1 integrated into the 
electronic medical record may provide the highest level of benefit.  
 Individuals with ADHD often have difficulty keeping appointments (J.R. Wilson, 
personal communication, April 4th, 2014).  One may deduce that this could have hypothetically 
45 
 
impeded the provider’s ability to screen for ADHD.  Conversely, missing an appointment could 
elicit a red flag to the provider to screen for ADHD in the future.   
 Although healthcare professionals were provided an introduction to the project face to 
face; sent e-mails on separate occasions; and provided binders with explicit instruction; in 
hindsight, a more formal training session may have been beneficial.  Such training could have 
included an in-service elaborating on adult ADHD and the benefit of improving the screening 
and identification process; an engaging lunch session; or a session at a local provider conference. 
 From the identified limitations of the study, the co-investigator has several 
recommendations for future research in adult ADHD.  First, sustaining a larger sample size may 
be helpful. Taking measures to ensure a larger participation rate would be essential for future 
studies. Possible ways to provoke a larger sample size include offering a more formal training, 
such as an in-service or education at a local conference, as mentioned previously, to healthcare 
professionals about adult ADHD and intentions of the project.  Easy access to the ASRS v1.1 
copies is also important to increase the likelihood of use in the primary care setting.  Lastly, 
patients frequently “no showing” for appointments should likely be screened for ADHD if no 
established diagnosis is in place.   
Project Implications for the Nurse Practitioner 
 ADHD is evident in most cultures, and accounts for 5 percent of children and 2.5 percent 
adult populations (APA, 2013).  The National Association for Continuing Education (n.d.) 
recognizes lack of knowledge and misinterpretations of adult ADHD.  Dr. Joel Wilson identified 
a need to improve the screening and referral process of adult ADHD in a rural Midwestern 
facility, thus the DNP practice improvement project was created with the help of numerous 
outstanding and professional individuals.  In alignment with Healthy People 2020’s (2013) goal 
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of increasing the proportion of adults with mental health disorders who receive treatment; the 
researcher, along with assistance from committee members, created two practice improvement 
project objectives. Improving screening and identification of adults with undiagnosed ADHD 
should result in proper treatment.  Secondly, by augmenting healthcare provider’s knowledge of 
ADHD, an essential result should be increasing the screening, identification, and treatment of 
individuals who currently remained undiagnosed with a mental health disorder.   
 Nurse practitioners, as well as other healthcare providers, are typically first line in 
identifying mental health disorders (J.R. Wilson, personal communication, April 4th, 2014).  
Knowledge of mental health disorders is essential for primary care providers.  ADHD is a 
neurodevelopment disorder with a childhood onset established before age 12 (APA, 2013; Nigg, 
Butler, Huang-Polluck, & Henderson, 2002).   The disorder was once thought to only exist in 
childhood; however, recent evidence demonstrates otherwise (APA, 2013; Dalsgaard, 2015; 
McGough & Barkley, 2004).  Struggles faced for individuals with disorder include atypical 
levels of inattention, impulsivity, and hyperactivity in common environments (APA, 2013; 
DuPaul, Weyandt, & Janusis, 2011).  When questioning if a patient has adult ADHD, the 
primary care provider should be aware that the patient must have been struggling with symptoms 
prior to the age of 12.  This bit of information is crucial in the diagnosis of adult ADHD.   
 Patients presenting to primary care for any type of visit displaying signs and/or symptoms 
of inattention; impulsivity; hyperactivity; depression; anxiety; substance abuse; changing jobs 
frequently; numerous motor vehicle accidents or traffic violations undoubtedly need to be 
screened for adult ADHD (Adler & Shaw, 2011).  Consequences of not screening include 
patients having lower occupational statuses; difficulty with relationships; more misconduct 
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offenses; and higher divorce rates (Faraone et al., 2000; Muhammad et al., 2011; Von Polier, 
Vloet, & Herpertz-Dahlman, 2012; Wilens et al., 2004).  
Personal Growth and Development 
 Conducting a practice improvement project demonstrated quite a challenge for the co-
investigator.  Finding a topic which could be guided locally by the researcher in primary care 
took several months to institute and would not have been established without a number of very 
important, intelligent, and supportive individuals.  Deep reflection was accomplished by the 
researcher prior, during, and after completion of the project. As a whole, nurse practitioners’ 
main goals in providing care are health promotion and disease prevention.  Hence, what does 
“health” actually mean?  The definition of health is multifaceted.  The researcher believes a 
holistic approach to defining health is imperative.   The following is the researcher own 
definition of health: 
“Health is a perception of one’s physical, mental, and social well-being.  Health is 
inseparable from one’s environment, family, and community.  All of the above-
mentioned factors may greatly impact one’s health, positively or negatively.  Biological, 
psychological, sociological, ethnological and spiritual factors can greatly influence one’s 
health as well. Adaptability to these factors plays a key role in one’s quality of life.” 
 
Signifying one’s desires to contribute to society requires deep reflection of values, 
expectations, and life experiences.  A passionate area of interest for the researcher is mental 
health, thus was chosen as the focus of this project.  As specified by the previously mentioned 
definition of health, mental health affects all other aspects of one’s life; such as physical health; 
social well-being; environmental conditions; and relationships with families and the community.  
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The researcher felt addressing an area of mental health would be the most meaningful for her and 
the community. 
Another challenge for the researcher was instigating contact with professionals whom 
may have been accommodating to the project.  Difficulty did not lie in the lap of the 
professionals; but instead was the researcher’s perception of the potential rejection faced.  
Forcing oneself to initiate contact with professionals was a challenge in itself.  After conquering 
the perceived challenge; self-worth, leadership, professionalism was realized.  Tackling a large 
and career-focused project can be quite overwhelming.  Importance is paid to decreasing 
distractions; reflecting on importance of the project; and lastly; knowing at least one person’s life 
was made easier because of the practice improvement project.  Looking to the future, knowledge 
and experience gained from the dissertation project will assist the researcher in defeating 
upcoming obstacles and provide her with the confidence to initiate future and necessary changes 
in healthcare. Continued leadership, passion, and professionalism will be essential throughout the 
researcher’s nursing career.   
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APPENDIX A. ADULT ADHD SELF-REPORT SCALE SYMPTOM CHECKLIST 
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APPENDIX B. THE IOWA MODEL OF EVIDENCED-BASED PRACTICE 
ALGORITHM 
 
 
 
 
 
60 
 
APPENDIX C. EVALUATION OF THE ASRS V1.1 
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APPENDIX D. E-MAIL TO HEALTHCARE PROVIDERS 
Dear Providers: 
 
My name is Taryn Treumer. I am a nurse practitioner student from North Dakota State 
University (NDSU). I was able to speak with a few of you at a recent provider meeting in regards 
to implementation of my project at Sanford.  I have now received IRB approval from NDSU and 
Sanford for the study involving implementation of the Adult ADHD Self-Report Scale (ASRS 
V1.1) in the primary care setting.  The purpose of the project is to improve screening practices 
for adult ADHD in the primary care clinic setting.  If a patient presents to the clinic with signs 
and/or symptoms of adult ADHD or your own history taking suggests there may be a problem, 
the ASRS V1.1 would be a useful screening tool.  The tool is not meant to be used to diagnose 
adult ADHD.  The ASRS V1.1 is a six item questionnaire that can be completed by the patient 
without supervision.   
 
Beginning on July 31st, 2014, you will notice a bright, green binder at each nurses' station, 
labeled "Adult ADHD Study". The binder will provide you with explicit instructions for use 
and scoring of the tool, copies of the ASRS V1.1, and other valuable information. 
 
Please remember that your participation is completely voluntary and you are in no way obligated 
to participate in the study; however, your participation will be greatly appreciated. If you 
have any questions or concerns, please feel free to contact me 
at taryn.n.treumer@ndsu.edu or 701.320.5583. You many also contact Dr. Joel Wilson via 
phone or e-mail with any immediate concerns or questions. Thank you for time and efforts. 
  
Sincerely, 
 
Taryn Treumer 
NDSU FNP Student 
taryn.n.treumer@ndsu.edu 
701.320.5583 
 
 
  
62 
 
APPENDIX E. E-MAIL TO HEALTHCARE PROFESSIONALS 
Dear healthcare professionals: 
 
My name is Taryn Treumer. I am a nurse practitioner student from North Dakota State 
University (NDSU). I am conducting a study in regards to adult ADHD. The study will be 
conducted at the 2nd and 5th Ave Sanford Health clinics in Jamestown.   
 
I have received Institutional Review Board (IRB) approval from NDSU and Sanford for this 
study, which involves implementation of the Adult ADHD Self-Report Scale (ASRS V1.1) in the 
primary care setting.  The purpose of the project is to improve screening practices for adult 
ADHD.  Providers may indicate to you he or she would like the patient to use this screener. It 
may also be helpful to remind providers that this screening tool is available.  
 
Intentions are to begin the study on July 31st, 2014. You will notice a bright, green binder 
at each nurses' station, labeled "Adult ADHD Study" on this date.  The binder will provide 
you with explicit instructions for use and scoring of the tool, copies of the ASRS V1.1, and other 
valuable information. 
 
Please remember that your participation is completely voluntary and you are in no way obligated 
to participate in the study; however, your participation will be greatly appreciated.  
 
If you have any questions or concerns, please feel free to contact me 
at taryn.n.treumer@ndsu.edu or 701.320.5583. You many also contact Dr. Joel Wilson via 
phone or e-mail with any immediate concerns or questions. Thank you for time and efforts. 
  
Sincerely, 
 
Taryn Treumer 
NDSU FNP Student 
taryn.n.treumer@ndsu.edu 
701.320.5583 
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APPENDIX F. PROJECT INSTRUCTIONS FOR HEALTHCARE PROVIDERS 
NDSU N O R T H  D A K O T A  S T A T E  U N I V E R S I T Y 
   Department of Nursing 
   College of Pharmacy, Nursing, and Allied Sciences 
   NDSU Dept. 2670 
   136 Sudro Hall, PO Box 6050 
   Fargo, ND 58108-6050 
   701.231.7395 
 
Title of Research Study:  Adult ADHD Self-Report Scale: Implementation in a 
Primary Care Setting 
 
 
Instructions: 
 
1. Consider administering the Adult ADHD Self-Report Scale version 1.1 (ASRS-v1.1) to 
individuals, age 18 and older, presenting with signs and/or symptoms of ADHD, whom do not 
currently have an adult ADHD diagnosis.   
 
2. Give the individual the participant form which explains the project. The form must be given 
prior to administering the ASRS-v1.1. The form explains demographic data gathered, 
confidentiality of the project, and that participation is completely voluntary.   
 
3. If the individual agrees, administer the ASRS-v1.1. The ASRS-v1.1 can be given to 
participant to be completed at any time during the office visit. It is a self-report scale; therefore, 
the provider or healthcare professional does not need to be present while the patient completes 
the 6-item questionnaire. However, this form should not be administered in the waiting room or 
in public areas for ANY reason.  
 
4. To score the ASRS-v1.1, observe the checkmarks in the shaded area. Four (4) or more 
checkmarks indicate the individual may have symptoms consistent with Adult ADHD. This does 
not indicate the patient is diagnosed with ADHD. Further screening and diagnostic testing may 
be necessary. Referral to a psychologist or psychiatrist may be appropriate.  
 
5. The original document of the ASRS-v1.1 must be kept with the patient’s medical record. A 
copy of the completed ASRS-v1.1 needs to be retained for the project. If a label is already on 
the ASRS-v1.1, it will be vital to “black out” any identifying information, as the researcher 
cannot know this information for the purposes of the study. If able, it would be appreciated if the 
patient’s age, sex, and if a referral was made could be written on the ASRS-v1.1. Preference to 
copy the ASRS-v1.1 prior to placing a label is the preferred method. Copies should be kept in 
the BRIGHT GREEN folder at the nurses’ station.  
 
 
64 
 
APPENDIX G. ATTENTION DEFICIT HYPERACTIVITY DISORDER FACTS FOR 
HEALTHCARE PROFESSIONALS  
NDSU N O R T H  D A K O T A  S T A T E  U N I V E R S I T Y 
   Department of Nursing 
   College of Pharmacy, Nursing, and Allied Sciences 
   NDSU Dept. 2670 
   136 Sudro Hall, PO Box 6050 
   Fargo, ND 58108-6050 
   701.231.7395 
 
Title of Research Study:  Adult ADHD Self-Report Scale: Implementation in a 
Primary Care Setting 
 
 
ADHD Facts:   
• Prevalence: 5% of children; 2.5 percent of adults 
 
• Inattention is most common symptom in adults 
 
• Genetic, environmental, and biological etiology: 
o Likely to have a 1st degree relative with the disorder 
 
• Common comorbidities: Mood, conduct, and substance abuse disorders 
 
Adult ADHD Self-Report Scale version 1.1 (ASRS-v1.1) 
• Created by an expert committee of psychiatrists and researchers: 
o Panel: Lenard Adler, MD; Ronald Kessler, PhD; Thomas Spencer, MD 
 
• Copyrighted by the World Health Organization (WHO) 
 
• Sensitivity:  68.7% & Specificity:  99.5% 
 
• Permission to use ASRS-v1.1 granted by Dr. Kessler and WHO.   
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APPENDIX H. ADULT ADHD SELF-REPORT SCALE SYMPTOM CHECKLIST                               
UTILIZED FOR THE PROJECT 
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APPENDIX I. HEALTHCARE PROVIDER INFORMED CONSENT 
NDSU N O R T H  D A K O T A  S T A T E  U N I V E R S I T Y   
   Department of Nursing 
   College of Pharmacy, Nursing, and Allied Sciences 
   NDSU Dept. 2670 
   136 Sudro Hall, PO Box 6050 
   Fargo, ND 58108-6050 
   701.231.7395 
 
Title of Research Study:  Adult ADHD Self-Report Scale: Implementation in a 
Primary Care Setting 
 
 
Dear healthcare provider, 
 
My name is Taryn Treumer. I am a graduate student in the Nursing Department at North Dakota 
State University, and I am conducting a practice improve project to improve screening practices 
for adult Attention Deficit/Hyperactivity Disorder (ADHD) in the primary care clinic setting. 
Currently, there is not a screening tool or protocol being used to identify individuals with the 
potential for adult ADHD at this facility. Hopes are to improve screening practices and 
identification of adults with undiagnosed adult ADHD by implementing a screening tool 
specifically designed by a group of ADHD experts.  
  
Because you are a healthcare provider, you are invited to take part in this project. Your 
participation is entirely your choice, and you may change your mind or quit participating at any 
time, with no penalty to you. 
 
If you choose to participate in this project, intentions are to screen individuals with signs, 
symptoms, or comorbid conditions associated with adult ADHD utilizing the adult ADHD Self-
Report Scale version 1.1 (ASRS-v1.1) after I have reviewed and given you instructions on the 
use of the instrument. Administering the ASRS-v1.1 will be entirely at the discretion of, you, the 
healthcare provider. Patients need to be informed that by completing the screen, statistical 
information will be gathered for a practice improvement project and he or she has the right to 
refuse completing the ASRS-v1.1. Only the patient’s age and sex will be gathered and will in no 
way be linked with the results of the screening. If the patient completes the ASRS-v1.1, a 
positive screen should warrant further investigation of adult ADHD. Referral to a psychologist or 
psychiatrist may be appropriate. The tool should take no longer than 3 minutes to administer. 
The anticipated end date of the project is December 2014 to May 2015. At the end of the project 
a brief evaluation survey in regards to the use of the ASRS-v1.1 will be distributed. The survey 
should take no longer than 5 minutes. Feedback given will remain anonymous. I will be the only 
individual from the study having access to the completed ASRS-v1.1 forms and evaluation 
surveys.  
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It is not possible to identify all potential risks in practice improvement projects, but my 
dissertation committee and I have taken reasonable safeguards to minimize any known risks.  
There are minimal risks associated with administering the ASRS-v1.1 and evaluation survey are 
marginal to you and your patients.  
If you have any questions about this project, please contact me at 701-320-5583 or 
Taryn.N.Treumer@ndsu.edu. You may also contact my advisor, Dr. Dean Gross at 701-231-
8355 or Dean.Gross@ndsu.edu.   
 
You have rights as a participant.  If you have questions about your rights or complaints about this 
project, you may talk to the investigator or contact the NDSU Human Research Protection 
Program at 701.231.8908, toll-free at 1-855-800-6717, by email at ndsu.irb@ndsu.edu, or by 
mail at:  NDSU HRPP Office, NDSU Dept. 4000, P.O. Box 6050, Fargo, ND 58108-6050; or 
contact Sanford Health Institutional Review Board at 605-312-6430. 
By administering the adult ASRS-v1.1, you are giving your consent and are freely making a 
decision to participate in this practice improvement project. Again, you may quit participating at 
any time throughout this project.  
 
Thank you for your taking part in this project.  If you wish to receive a copy of the results, please 
contact me or my advisor. 
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APPENDIX J. PATIENT INFORMED CONSENT 
NDSU N O R T H  D A K O T A  S T A T E  U N I V E R S I T Y 
   Department of Nursing 
   College of Pharmacy, Nursing, and Allied Sciences 
   NDSU Dept. 2670 
   136 Sudro Hall, PO Box 6050 
   Fargo, ND 58108-6050 
   701.231.7395 
 
Title of Research Study:  Adult ADHD Self-Report Scale: Implementation in a Primary Care 
Setting 
 
 
Dear Participant: 
 
My name is Taryn Treumer.  I am a graduate student in the Nursing Department at North Dakota State University, 
and I am conducting a practice improvement project to help better identify any patients whom might be suffering 
from adult ADHD.  It is our hope, that with this practice improvement project, we will learn more about the 
screening process and identification of adults with the potential for an adult ADHD diagnosis.  
 
Because you are at this healthcare clinic and may be displaying signs and symptoms consistent with adult ADHD, 
you are invited to take part in this research project.  Your participation is entirely your choice, and you may change 
your mind or quit participating at any time, without penalty to you. 
 
It is not possible to identify all potential risks in research procedures, but my dissertation supervisory committee and 
I have taken reasonable safeguards to minimize any known risks. Currently, there are no known identifiable risks. A 
potential risk of psychological or emotional distress could occur from completing the 6 instrument questionnaire.  
 
By taking part in this research, you may potentially benefit by being assessed and referred for help. However, you 
may not get any benefit from being in this study. Benefits to others and society are likely to include advancement of 
the knowledge of adult ADHD and improvement in the screening process for adults with the potential for ADHD in 
the primary care setting. 
 
The screening survey should take about 2-3 minutes to complete with questions about your daily life. Please answer 
the questions to the best of your ability. As you answer each question, place an X in the box the best describes how 
you have felt and conducted yourself over the past 6 months.  
 
We will keep private all research records that identify you.  The only information that will be gathered and used is 
your age and sex. Your information will be combined with information from other participants taking part in the 
project and we will write about the combined information that we have gathered.  You will not be identified in any 
written materials. We may publish the results of the project; however, we will keep your name and other identifying 
information private. 
 
If you have any questions about this project, please contact me at 701.320.5583 or Taryn.N.Treumer@ndsu.edu, or 
contact my advisor, Dr. Dean Gross at 701.235.8355 or Dean.Gross@ndsu.edu  
 
You have rights as a research participant.  If you have questions about your rights or complaints about this research, 
you may talk to the researcher or contact the NDSU Human Research Protection Program at 701.231.8908, toll-free 
at 1-855-800-6717, by email at ndsu.irb@ndsu.edu, or by mail at:  NDSU HRPP Office, NDSU Dept. 4000, P.O. 
Box 6050, Fargo, ND 58108-6050; or contact Sanford Health Institutional Review Board at 605-312-6430. 
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APPENDIX K. WORLD HEALTH ORGANIZATION PERMISSION TO USE ASRS V1.1 
Dear Ms Treumer, 
  
Thank you for completing the online form and for interest in WHO health informations products.  
  
On behalf of the World Health Organization, we are pleased to authorize your request to reproduce the 
WHO item detailed in the form below. 
  
This permission is subject to the following conditions:  
  
• This is a non-exclusive permission to reproduce the material detailed below. 
• Please ensure that the original WHO source is appropriately acknowledged with the appropriate 
bibliographical reference including publication title, author, publisher, volume/edition number, page 
numbers, copyright notice year and the URL reference and the date accessed. Suggested example 
below. 
• The material will be reproduced as it was published by WHO and no changes should be made to 
the content or meaning. Publishers may reformat the material in the style of the publication. 
• The use of WHO materials should be factual and used in an appropriate context; 
• The material should not be reproduced for use in association with product marketing or promotional 
activities. In no event should the WHO information products be used in promotional materials eg 
products brochures, or company-sponsored web sites, annual reports, or other publications for 
distribution to, and/or non-educational presentations for, either the general public, or pharmacists, 
doctors, nurses, etc. 
• There should be no suggestion that WHO endorses any specific company or products in the article, 
book etc or in the manner of distribution of the article, book etc. 
• The WHO logo and emblem shall not be reproduced. 
  
All reasonable precautions have been taken by the World Health Organization to verify the information 
contained in its published material. However, the published material is being distributed without warranty of 
any kind, either expressed or implied, and you are entirely responsible for reproducing and displaying the 
material in your publication.  In no event shall the World Health Organization be liable for damages arising 
from its use.  
  
WHO reserves the right to withdraw the permission in the event a condition is not respected 
  
WHO will not charge a fee for the above permission, however we would be grateful if you could send one 
copy of the final product for our records, showing where/how WHO material appears and how it is 
referenced on your product addressed to: 
  
Ms Dolores Campanario 
World Health Organization Press 
WHO Press WHP (Permissions Management) 
20 Avenue Appia, Office 4152  
CH-1211 Genève 27, Switzerland 
campanariod@who.int 
  
We thank you for your interest in WHO Information products and we wish you all the best with your project. 
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Kind regards. 
  
Ms Dolores Campanario 
World Health Organization Press  - (Permissions Management, Licensing and Reprint Rights) 
Department of Knowledge Management and Sharing  
20 Avenue Appia, Office: 4152, CH-1211 Genève 27, Switzerland 
Tel: +41 22 791 24 83 - Fax: +41 22 791 4857 - E-mail: campanariod@who.int 
Direct Links: 
To request for permission to reproduce parts or complete reprints of WHO copyrighted materials, complete this form -
http://www.who.int/about/licensing/copyright_form/en/index.html 
To order WHO publications on sale - http://apps.who.int/bookorders/ 
  
  
  
Suggested examples for references: 
  
Reproduced, with the permission of the publisher, from Traditional medicine, Geneva, World Health Organization, 2008 (Fact 
sheet no. 134; http://www.who.int/mediacentre/factsheets/fs134/en/, accessed 13 May 2011)” 
  
“Reproduced, with the permission of the publisher, from the World Health Report: Health Systems Financing: The Path to 
Universal Coverage. Geneva, World Health Organization, 2010 (Fig. 5.1, Page 
92http://whqlibdoc.who.int/whr/2010/9789241564021_eng.pdf, accessed 04 April 2013)” 
  
If authorship is attributed to individual authors or a group:  
“Reproduced, with the permission of the publisher, from Smith AB, Jones CD, Title. Geneva, World Health Organization, 2013.” 
  
"Please note that if the requested item was jointly produced with other organization/s outside WHO or if not originally produced by 
WHO source, then please, also make every effort to obtain permissions from the appropriate external sources as mentioned on the 
original product details." 
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APPENDIX L. PERMISSION TO USE ASRS V1.1 FROM DR. KESSLER 
Dear Taryn, 
Thank you for contacting Dr. Kessler regarding the use of the ADHD-ASRS v1.1.  
Use of the ASRS is free and does not require any formal permission or approval. We do, 
however, ask that you please cite the below article when using the ASRS. Should you publish 
any work that uses the ASRS, please send us the citations to all final publications. 
 
Kessler, R.C., Adler, L., Ames, M., Demler, O., Faraone, S., Hiripi, E., Howes, M.J., Jin, R., 
Secnik, K., Spencer, T., Ustun, T.B., Walters, E.E. (2005). The World Health Organization Adult 
ADHD Self-Report Scale (ASRS). Psychological Medicine, 35(2), 245-256 
Please feel free to follow-up with me should you have any additional questions regarding the use 
of the ASRS.   
Kind regards, 
Avery Borreliz 
  
Avery Borreliz 
Research Assistant 
Department of Health Care Policy 
Harvard Medical School 
180A Longwood Ave. 
Boston, MA 02115 
  
617-432-2634 
Borreliz@hcp.med.harvard.edu 
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APPENDIX M. PERMISSION TO USE THE IOWA MODEL 
Permission to Use and/or Reproduce The Iowa Model  
Kimberly Jordan - University of Iowa Hospitals and Clinics <noreply@qemailserver.com>  
Mon 1/19/2015 10:28 AM 
To: Taryn Treumer;  
To help protect your privacy, some content in this message has been blocked. To re-enable the 
blocked features, click here.  
To always show content from this sender, click here.  
You have permission, as requested today, to review/use The Iowa Model of Evidence-Based 
Practice to Promote Quality Care (Titler et al., 2001). Click the link below to open the model. 
Copyright of the Iowa Model of Evidence-Based Practice to Promote Quality Care will be 
retained by The University of Iowa Hospitals and Clinics. 
 
Permission is not granted for placing the Iowa Model on the internet. 
The Iowa Model  
   
In written material, please add the following statement: 
• Used/Reprinted with permission from the University of Iowa Hospitals and Clinics and 
Marita G. Titler, PhD, RN, FAAN. Copyright 1998. For permission to use or reproduce 
the model, please contact the University of Iowa Hospitals and Clinics at (319)384-9098
.  
 If you have questions, please contact Kimberly Jordan at 319-384-9098 or kimberly-
jordan@uiowa.edu. 
 
 
 
 
 
73 
 
APPENDIX N. NORTH DAKOTA STATE UNIVERSITY INSTITUTIONAL REVIEW 
BOARD APPROVAL 
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APPENDIX O. SANFORD INSTITUTIONAL REVIEW BOARD APPROVAL 
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APPENDIX P. COLLABORATIVE INSTITUTIONAL TRAINING INITIATIVE  
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APPENDIX Q. NORTH DAKOTA STATE UNIVERSITY INSTITUTIONAL REVIEW 
BOARD ADDENDUM  
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APPENDIX R. SANFORD INSTITUTIONAL REVIEW BOARD ADDENDUM  
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APPENDIX S. REMINDER E-MAIL TO HEALTHCARE PROVIDERS 
 
Dear Providers and Healthcare Professionals: 
 
My name is Taryn Treumer. I am a nurse practitioner student from North Dakota State 
University (NDSU). I am sending out an e-mail reminder to utilize Adult ADHD Self-Report 
Scale (ASRS V1.1) screening tool if a patient presents with signs and/or symptoms of ADHD. 
Please remember your participation in this study is completely voluntary and you are in no way 
obligated to use the ASRS V1.1.  
 
There should be a green binder at each nurse’s station with guidance and instruction about the 
process. Please refer to the binder or contact myself or Dr. Wilson with any questions or 
concerns. My contact information is: taryn.n.treumer@ndsu.edu or 701.320.5583. I will be 
checking the green folders for completed ASRS’s at weekly to monthly intervals.  
 
Below is a list of signs/symptoms or red flags that may prompt you to use the ASRS V1.1: 
 
• Substance abuse 
• Frequently changing jobs/inability to keep a job 
• Inattentive/distracted 
• Comorbid conditions, such as anxiety or depression 
• Frequent traffic violations 
• 1st degree relative with ADHD 
• Problems in school 
• Inability to complete tasks/projects 
 
The tool is not meant to be used to diagnose adult ADHD.  Your participation in this study is 
greatly appreciated. Thank you for your time and efforts. 
  
Sincerely, 
 
Taryn Treumer 
NDSU FNP Student 
taryn.n.treumer@ndsu.edu 
701.320.5583 
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APPENDIX T. EXECUTIVE SUMMARY 
Project Summary 
The purpose of this project was two-fold.  The first aim was to improve the screening and 
identification of adults with undiagnosed adult ADHD for appropriate referral and treatment 
utilizing the ASRS v1.1.  In order to accomplish this task an additional goal was created to 
enhance healthcare professionals’ knowledge and awareness of adult ADHD.   The researcher 
and committee members designed the project to be minimally stressful for willing participants.  
Factors considered included ease of use of the instrument; practicality; and benefits to the 
healthcare professionals and patients.   
Background 
Implementation of the ASRS v1.1 in a primary care setting originated because of an 
identified need to improve the process of screening for adult ADHD in a rural, Midwestern 
healthcare facility.   
• Attention Deficit/Hyperactivity Disorder (ADHD) is a chronic, highly prevalent, 
neurodevelopment disorder in children, which may persist into adulthood (American 
Psychiatric Association [APA], 2013; Knutson & O’Malley, 2009; Nigg, Butler, 
Huang-Pollock, & Henderson, 2002).  
• There are an increasing number of adults presenting in primary care with signs and/or 
symptoms which may be related to undiagnosed ADHD (Matheson et al., 2013; 
Rostain & Ramsay, 2006).   
• Adults with undiagnosed ADHD typically present with comorbid conditions, such as 
anxiety, depression, substance abuse, and other psychosocial burdens related to a 
chronic sense of failure or missed potential in life (Matheson et al., 2013).   
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• Primary care health providers play a pivotal role in identifying individuals with 
mental health disorders.   
• Identification and treatment of ADHD can help individuals reach their full potential, 
improving one’s overall quality of life (National Association for Continuing 
Education [NACE], n.d.).  
• A gap exists among healthcare providers’ knowledge of adult ADHD and current 
screening practices in the primary care setting based on a thoroughly conducted 
literature review.   
o One way to develop a consistent screening process would be by the use of an 
adult ADHD rating scale.   
 Rating scales are valuable because they enable clinicians to obtain 
large amount of data relatively quickly, including information on 
presence and severity of symptoms (Buitelaar, Kan, & Asherson, 
2011). 
o The adult ADHD Self-Report Scale version 1.1 (ASRS-v1.1) is a six question 
screener which has demonstrated good sensitivity (68.7%) and specificity 
(99.5%) (Harvard Medical School, 2005).  
o The ASRS v1.1 was developed by a group of ADHD experts and copyrighted 
by the World Health Organization (Harvard Medical School, 2005).  
Process 
 In order to establish the most convenient process to implement the ASRS v1.1 and reduce 
workload of the project for volunteers, the researcher consulted with the involved psychologist of 
the intended facility as well as the supervising nurse on several occasions.   
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• A decision was made to have binders containing copies of the ASRS v1.1, consent form, 
and other pertinent resources at each nurses’ station.   
• Healthcare providers and nurses were given project information in numerous formats. 
The co-investigator attended a facility meeting to introduce the project idea to the 
healthcare providers.   
o E-mails were sent to healthcare providers and nurses prior to launching the project 
as well as thereafter to remind the healthcare professionals about the ASRS v1.1. 
o Appropriate use and instruction of the ASRS v1.1 was also provided within the 
binder on the first page. 
Healthcare professionals were instructed to administer to the ASRS v1.1 to adult patients 
presenting to primary care for a wellness or episodic visit displaying signs and/or symptoms of 
ADHD.   
• Signs and symptoms may include, but are not limited to: substance abuse; anxiety; 
depression; inattention; hyperactivity; impulsivity; frequently changing jobs; and no 
current ADHD diagnosis (Adler & Shaw, 2011).   
• The project coordinator checked the binders for completed forms periodically, 
ranging from weekly to monthly.   
• The implementation of the ASRS v1.1 began July 29th, 2014 and ceased December 
31, 2014.   
• A voluntary survey evaluation of the ASRS v1.1 was delivered to providers 
thereafter.  
• Those who chose to participate returned the evaluation via postal mail within four 
weeks.   
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• Data examination of the completed screeners and evaluation surveys were analyzed 
by the project coordinator.   
Findings 
 The implementation of the ASRS v1.1 in the primary care setting began on July 29th, 
2014 and December 31st, 2014.  The providers were allotted approximately four weeks to 
complete the survey evaluation forms post-implementation of the ASRS v1.1.  
• Total number of patient participants screened in primary care was 20.   
o The entirety of positive screens substantiated was 16.  Of the 16 positive screens, 
only three were documented on the screener as referred; however, it is unknown if 
more patients were actually referred for additional care.   
• Healthcare providers choosing to participate in the study totaled six.   
o Five providers completed the evaluation form.  
• Subjective information provided reinforced an enhancement in the screening process for 
adults with undiagnosed ADHD were achieved.   
o Providers described the tool as exceptionally valuable as well as affording 
simplicity to primary care providers.  
o ASRS v1.1 is straightforward, efficient, and precise. 
 A barrier of the tool is that patients could replicate a positive result due to 
the face validity of the tool.  
• Objective One: Increase screening of adult with undiagnosed ADHD using the adult 
ASRS v1.1.  
o Goal met: The involved psychologist established an increase in referrals for 
patients with undiagnosed ADHD.  
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•  Objective Two: Enhance healthcare professionals’ knowledge and awareness of adult 
ADHD.   
o Goal met. None of the primary care providers employed at the Midwestern 
regional facility were aware of the ASRS v1.1. Three of the five providers felt 
their knowledge level of ADHD increased.  
Recommendations 
 From the practice improvement project, several recommendations were ascertained.   
• Configure appropriate sample size prior to initiation of the project.  
• Screen patients identified as routinely missing appointments for ADHD. 
• Ensure ease of access of the ASRS v1.1 for screening purposes 
o Have screener in the exam room or integrated into the electronic medical record.   
• Offer a formal training and/or educational in-service for healthcare professionals about 
adult ADHD and the practice improvement project.  
Conclusion 
The National Association for Continuing Education (n.d.) recognizes lack of knowledge 
and misinterpretations of adult ADHD.  A need to improve the screening and referral process of 
adult ADHD in a rural Midwestern facility was recognized.  Primary care providers are typically 
first line in identifying mental health disorders; thus, a practice improvement project was created 
to improve screening and identification of adults with undiagnosed ADHD.  Secondly, 
augmentation of healthcare provider’s knowledge of adult ADHD may enhance screening; 
identification; and treatment of individuals who currently remained undiagnosed with the 
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disorder, ultimately improving one’s overall quality of life, creating an opportunity to reach 
one’s fullest potential.  
   
 
 
